160 related articles for article (PubMed ID: 10582662)
21. Assessment of the protective effects of amifostine against cisplatin-induced toxicity.
Hussain AE; Blakley BW; Nicolas M; Balderston J
J Otolaryngol; 2003 Oct; 32(5):294-7. PubMed ID: 14974858
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human erythropoietin in comparison to amifostine against cisplatin-induced peripheral sensorial neurotoxicity in rats.
Yalcin S; Kilickap S; Temucin CM; Erman M
J Exp Clin Cancer Res; 2006 Dec; 25(4):523-7. PubMed ID: 17310843
[TBL] [Abstract][Full Text] [Related]
23. Amifostine protective effect on cisplatin-treated rat testis.
Lirdi LC; Stumpp T; Sasso-Cerri E; Miraglia SM
Anat Rec (Hoboken); 2008 Jul; 291(7):797-808. PubMed ID: 18543292
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.
McKibbin T; Panetta JC; Fouladi M; Gajjar A; Bai F; Okcu MF; Stewart CF
Clin Cancer Res; 2010 Feb; 16(3):1049-57. PubMed ID: 20103669
[TBL] [Abstract][Full Text] [Related]
25. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Treskes M; van der Vijgh WJ
Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
[TBL] [Abstract][Full Text] [Related]
26. New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065.
Bai F; Kirstein MN; Hanna SK; Stewart CF
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):257-65. PubMed ID: 12007770
[TBL] [Abstract][Full Text] [Related]
27. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
28. Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro.
Konings PN; Makkink WK; van Delft AM; Ruigt GS
Brain Res; 1994 Mar; 640(1-2):195-204. PubMed ID: 7911725
[TBL] [Abstract][Full Text] [Related]
29. Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells.
Michelutti A; Stocchi R; Candoni A; Tiribelli M; Calistri E; Russo D; Fanin R; Damiani D
Cancer Chemother Pharmacol; 2006 Apr; 57(4):517-24. PubMed ID: 16001170
[TBL] [Abstract][Full Text] [Related]
30. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
[TBL] [Abstract][Full Text] [Related]
31. Neurologic protection by amifostine.
DiPaola RS; Schuchter L
Semin Oncol; 1999 Apr; 26(2 Suppl 7):82-8. PubMed ID: 10348265
[TBL] [Abstract][Full Text] [Related]
32. Curcumin Protects β-Lactoglobulin Fibril Formation and Fibril-Induced Neurotoxicity in PC12 Cells.
Mazaheri M; Moosavi-Movahedi AA; Saboury AA; Khodagholi F; Shaerzadeh F; Sheibani N
PLoS One; 2015; 10(7):e0133206. PubMed ID: 26186474
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
McDonald ES; Randon KR; Knight A; Windebank AJ
Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
[TBL] [Abstract][Full Text] [Related]
34. Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity.
List AF; Heaton R; Glinsmann-Gibson B; Capizzi RL
Semin Oncol; 1996 Aug; 23(4 Suppl 8):58-63. PubMed ID: 8783669
[TBL] [Abstract][Full Text] [Related]
35. Amifostine as a protector against cisplatin-induced toxicity in nude mice.
Johnsson A; Wennerberg J
Acta Oncol; 1999; 38(2):247-53. PubMed ID: 10227448
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.
Yalcin S; Nurlu G; Orhan B; Zeybek D; Müftüoğlu S; Sarer B; Yildirim BA; Cetin E
Med Oncol; 2003; 20(2):175-80. PubMed ID: 12835521
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of Ginkgo flavonoids, amifostine, and leuprorelin against platinum-induced ovarian impairment in rats.
Chang Z; Wang HL; Du H
Genet Mol Res; 2014 Jul; 13(3):5276-84. PubMed ID: 25078583
[TBL] [Abstract][Full Text] [Related]
38. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
39. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
[TBL] [Abstract][Full Text] [Related]
40. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
Grdina DJ; Murley JS; Kataoka Y; Calvin DP
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):103-11. PubMed ID: 11917294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
